| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |